Abstract:Objective: Current studies focus on the prevalence rate of lung cancer in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung disease (CTD-LID). Our aim was to investigate the prevalence of malignancies in patients with various subtypes of ILD. Methods: A total of 5350 patients diagnosed with ILD between January 2015 and December 2021 were retrospectively included. The prevalence of different malignancies and different ILDs was assessed using complete follow-up data. Results: A total of 248 patients (139 males; 65—IQR, 57 to 72—years) out of 5350 patients with ILD were confirmed with malignancies. A total of 69% of patients with ILD and malignances were older than 60 years old. The prevalence of malignancies in ILD patients was 4.6%, and lung cancer had the most common incidence of 1.9%, followed by malignancies in the digestive system of 0.9%. Among the different ILD subtypes, the prevalence of malignancies such as organizing pneumonia (OP), idiopathic pulmonary fibrosis (IPF), anti-neutrophil cytoplasmic antibodies-associated vasculitis-related ILD(AAV-ILD), nonspecific interstitial pneumonia (NSIP), CTD-ILD, hypersensitivity pneumonitis (HP), sarcoidosis, and other types of ILD was 6.8%, 5.0%, 4.7%, 4.3%, 2.5%, 2.2%, 1.2%, and 6.9%, respectively. The incidence of lung cancer as the most common tumor in IPF was 3.9%, with adenocarcinoma predominating (1.7%). The highest rate of malignancy occurring in RA of CTD-ILD was 2.4%. Conclusion: Older patients with ILD (≥60 years) including OP, IPF, AAV-ILD, NSIP, CTD-ILD, and HP, were associated with a higher incidence of malignancy, especially males aged from 60 to 69 years. These epidemiological results indicate that it is essential for physicians to pay more attention to the screening of and management strategies for different malignancies, according to the specific ILD subtypes.

Interstitial lung disease in the elderly: pathogenesis, diagnosis and management

Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management

Clinical features of idiopathic pulmonary fibrosis in the elderly

Causes of Pulmonary Fibrosis in the Elderly

Connective tissue diseases, multimorbidity and the ageing lung

Immune Checkpoint Inhibitors in Elderly Patients with Lung Cancer: Evidence from Phase 3 Trials.

Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities

Interstitial lung diseases: never forget to think about it in primary care

Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review

Progression of fibrosing interstitial lung disease

Current Challenges and Novel Therapeutic Perspectives

Malignancies in Patients with Interstitial Lung Diseases: A Single Center Observational Study

Diagnosis and Management of Fibrotic Interstitial Lung Diseases

Cellular Senescence in Lung Fibrosis

Interstitial lung disease revisited

Idiopathic fibrotic lung disease at a university hospital setting: management and prognostic factors

Complications of fibrotic interstitial lung disease for the general radiologist

Characterisation of incident interstitial lung disease in late systemic sclerosis